Otsuka Pharmaceutical Factory, Inc. manufactures and distributes pharmaceutical and nutritional products. Its products include medical foods, hine E-gel, processlead, engelead, innerpower, oronine h ointment, urepearl plus lotion 10 and urepearl plus cream. The company was founded on September 1, 1921 and is headquartered in Naruto, Japan.

Industry Academic Cooperation Foundation Hallym University is a private company headquartered in the South Korea. The firm provides office support services.

Jichi Medical University (自治医科大学 Jichi ika daigaku) is a private university in Shimotsuke, Tochigi, Japan, established in 1972. In 2008 the Gates Foundation awarded $100,000 to Hiroyuki Matsuoka, a medical researcher at the university, to do research on flying syringes.

Korea Medical Science Institute Co., Ltd. is a South Korean private company that provides research development in biotechnology services.

Peking University Third Hospital is a private company headquartered in Beijing, China, that operates as a clinic.

ICCAS was founded in 1956. ICCAS is a multi-disciplinary research institute dedicated to the basic research in broad fields of chemical sciences, and to the key developments of the innovative high technologies aiming to the imperative national needs and important strategic targets, as well as to the collaborative high-technology applications and transfers. ICCAS is one of China’s leading chemistry research institutions with high international reputation.

DAIKIN INDUSTRIES Ltd. engages in the manufacture and sale of air conditioning equipment. It operates through the following segments: Air Conditioner and Refrigerator, Chemicals, and Others. The Air Conditioner and Refrigerator segment deals with the manufacture, distribution, and installation of air conditioning and refrigeration equipment. The Chemicals segment offers fluorocarbon gas, fluororesin, and other chemical products such as semiconductor etching agent, water and oil repellent, surfactant, carbon fluoride, and fluorine oil. The Others segment covers oil machineries, special machineries, and electronic systems. The company was founded by Akira Yamada on October 25, 1924 and is headquartered in Osaka, Japan.

Shenzhen Shenjian Pharmaceutical Technology Co., Ltd., established on 2017-09-30, Business scope includes general business items:Biotechnology Development Services;Biotechnology Consulting,Chemical Reagent and Auxiliary Manufacturing(Monitor Chemicals,Excluding hazardous chemicals)biotechnology research,Development and Consulting;drug development,Technology Development and Transfer,Technical Consulting and Technical Services,medical technology development.,The licensing program is:

GC Cell Corp. engages in the research and development of cell curing agents and in the transport and sale of consignment inspection samples. It offers cell therapy products, cell banking, clinical laboratory services, clinical trials and bio logistics. The company was founded on June 21, 2011 and is headquartered in Yongin-si, South Korea.

Azbil Corp. engages in the design, development, manufacture, and sale of measurement and control equipment. It operates through the following business segments: Building Automation, Advanced Automation, Life Automation, and Other. The Building Automation segment supplies commercial buildings and production facilities with automatic heating ventilation, and air conditioning control and security systems. The Advanced Automation segment provides automation control systems, switches and sensors, and engineering and maintenance services to industrial plants and factories. The Life Automation segment offers meters for lifelines, residential central air-conditioning systems and life science research. It also manufactures and sells manufacturing and environmental equipment for pharmaceutical and medical fields. The Other segment handles insurance agency. The company was founded by Takehiko Yamaguchi on December 1, 1906 and is headquartered in Tokyo, Japan.

The National Institute of Advanced Industrial Science and Technology (AIST), led by President Chubachi, is a public research institution funded by the Japanese government to a large extent. The present AIST is a rather new research organization established in 2001. However, AIST and its predecessor organizations have been contributing to society through continuous advancement in technologies and support to Japanese industries since 1882. Headquarters of AIST are located in Tsukuba and Tokyo. AIST has over 40 autonomous research units in various innovative research fields, and the units are located at ten research bases and several sites (smaller than research bases) of AIST all over Japan. About 2300 researchers (about 2000 with tenure: about 80 from abroad) and a few thousands of visiting scientists, post-doctoral fellows, and students from home and abroad are working at AIST. About 650 permanent administrative personnel and many temporary staff support research works of AIST.

UAB Research Foundation (doing business as UABRF), a subsidiary of The University of Alabama System, is a company headquartered in Birmingham, AL. The firm engages in identify, assess, and market commercially viable technology developed at The University of Alabama at Birmingham.

National Center of Neurology and Psychiatry provides treatment and prevention therapy for mental, nervous, and developmental disorders.

ZENOAQ aims to create a shared and everlasting future for humans and animals. Amidst efforts to improve drug development, veterinary therapy and biotechnology, ZENOAQ strives to enhance the value of animals. The core activities in ZENOAQ are deeply connected with our customers, which in turn, affects their animals in many different ways. These connections form a network that is not just limited to Japan, but is something that will also reach across international borders, creating mutual benefit for both humans and animals in the future.

Anterogen Co., Ltd. engages in the development and sale of stem cell therapy treatments. Its products include Cupistem and Remodullin injection, Queencell, and stem cell conditioned media. It also offers stem cell banking and analysis services. The company was founded on March 16, 2000 and is headquartered in Seoul, South Korea.

Suzhou Yida Biotechnology Co., Ltd., established on 2014-11-03, The scope of business includes engaging in biological research,the medical,Instruments and accessories for beauty and health care,Consumables Research,to develop,production and sales,And provide related technology transfer,technical consulting,Technical Services;Engaged in the import and export business of the above products and technologies.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) licensed items:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Pharmaceutical special equipment manufacturing;Pharmaceutical special equipment sales;Specialty Chemicals Sales(Free of Hazardous Chemicals);Manufacturing of Drug Testing Instruments;Drug testing equipment sales(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Guangzhou Saliai Stemcell Science & Technology Co., Ltd. engages in the provision of stem cell storage, health supplements, biological products, and related health management services. The firm involves in the production of regenerative medicine devices, medical nutrition supplements, and biological & medical cosmetic products. It operates a research and development platform which includes life bank, health management center, medical center, and medical cell center. The company was founded by Hai Jia Chen and Ming Jia Chen on July 7, 2009 and is headquartered in Guangzhou, China.

Wuhan Inner's Pharmaceutical Co., Ltd., established on 2010-09-17, Business scope includes pharmaceutical products,Health Care Products,Technology research and technology transfer of biotechnology products;Chemical Products(except dangerous goods)research and development,Sales,Technical service and transfer;Investment in Education Industry(Does not contain national laws and regulations,Items restricted and prohibited by the State Council;Do not publicly raise and issue funds in any way)(Shall not engage in taking public deposits or taking public deposits in a disguised form,Not to engage in financial business such as granting loans);Educational Consulting(Excluding primary and secondary school culture education and training).(Projects subject to approval by law,Business activities can only be carried out after approval by relevant departments)

CEFO Co., Ltd. is a South Korean company located in Seoul that engages in research and development of stem cells. The firm was founded in 2011 by Hyeon-Suk Park, he has been the CEO since the company founding.